Celator Pharmaceuticals appoints new CEO
pharmaceutical-business-review.com
01-Oct-2008
        

US based Celator Pharmaceuticals has appointed Scott Jackson as the company's new CEO. Mr Jackson succeeds Andrew Janoff. Celator Pharmaceuticals appoints new CEO Celator reports positive results from Phase II colorectal cancer trial Mr Jackson joined Celator in October 2007 as head of commercial development. Mr Jackson has extensive experience in the pharmaceutical and biotechnology industry and has held positions of increasing responsibility in sales, marketing, and commercial... [read full story]                    

Add Comment
View all news articles about*:
BioSciences Board Centocor CEO Directors Eli General ImClone Issues Johnson Lilly Management Senior Systems
*Newstin tag cloud displays all featured persons, associated organisations, related topics, regions and companies

View other selected articles:

Johnson & Johnson In-House Counsel Joins Lovells

pharmiweb.co.uk
2 hrs ago 1 related
        

Law360, New York (December 04, 2008) -- International business law firm Lovells LLP said Thursday it has hired attorney Kevin Townsend, Johnson & Johnson's senior in-house counsel, to join its intellectual property practice as...

add comment

::: Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of...

pharmiweb.co.uk
1 hr ago
        

SAN DIEGO, Dec. 1 /PRNewswire-FirstCall/ -- Vical Incorporated (NASDAQ: VICL) announced today the receipt of a $1.0 million milestone payment from Merck & Co., Inc. based on Merck's planned initiation of a Phase I clinical...

add comment